President's Message
News Release
December 22, 2025
|
Press Release
NEW
Notice of Marketing Authorization for “RAVICTI® Oral Liquid 1.1 g/mL” for Urea Cycle Disorders
July 25, 2025
|
Press Release
Notice of Head Office Relocation (Change of Building)
December 25, 2024
|
Press Release
Announcement Regarding the Designation of Glycerol Phenylbutyrate as an Orphan Drug
December 25, 2024
|
Press Release
Announcement of Application for Approval of Glycerol Phenylbutyrate for the Treatment of Urea Cycle Disorder
September 24, 2024
|
Press Release
Announcement of Marketing Authorization Transfer for Rabipur Intramuscular Injection
We associate with the activities of Rare Disease Day JAPAN and support activities.
